TrademarkDir
HETSIFA
LIVE

Serial Number

88025090

Owner

FUZIONAIRE THERANOSTICS, INC.

Attorney

John W. Peck

First Use Date

Oct 8, 2021

Filing Date

Jul 3, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

HETSIFA Trademark

Serial Number: 88025090 • Registration: 6583852

HETSIFA is a trademark filed by FUZIONAIRE THERANOSTICS, INC. on July 3, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

FUZIONAIRE THERANOSTICS, INC. (3 trademarks)

2002 TIMBERLOCK PLACE, SUITE 200
THE WOODLANDS, TX 77380

Entity Type: 03

Fuzionaire, Inc. (3 trademarks)

Suite 200
The Woodlands, TX 77380

Entity Type: 03

Trademark Details

Filing Date

July 3, 2018

Registration Date

December 7, 2021

First Use Anywhere

October 8, 2021

First Use in Commerce

October 8, 2021

Published for Opposition

March 26, 2019

Goods & Services

Reagents and reagent kits comprised of biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, medical, theranostic, therapeutic, and quantitation reagents for use in radiolabels and radiopharmaceuticals for medical or veterinary purposes; biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, medical, theranostic, therapeutic, and quantitation reagents and reagent kits comprised of biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, medical, theranostic, therapeutic, and quantitation reagents for use in radiopharmaceuticals for clinical medical and veterinary diagnostic purposes

chemical preparations for scientific purposes; biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, theranostic, and quantitation reagents and reagent kits comprised of biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, theranostic, and quantitation reagents for scientific use for use in radiolabels for non-medical purposes; biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, theranostic, and quantitation reagents and reagent kits comprised of biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, theranostic, and quantitation reagents for scientific use for use in radiotracers for laboratory use; biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, theranostic, and quantitation reagents and reagent kits comprised of biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, theranostic, and quantitation reagents for scientific use for use in radiolabeled pharmaceutical candidates for non-medical laboratory evaluation and drug discovery purposes

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 12, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 12, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 12, 2026 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 1, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 1, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 1, 2023 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 13, 2023 ASGN
REGISTERED-PRINCIPAL REGISTER
Dec 7, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 4, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 3, 2021 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 20, 2021 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Oct 19, 2021 SUPC
SOU EXTENSION 5 GRANTED
Oct 19, 2021 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 19, 2021 AITU
USE AMENDMENT FILED
Oct 13, 2021 IUAF
SOU EXTENSION 5 FILED
Oct 13, 2021 EXT5
SOU TEAS EXTENSION RECEIVED
Oct 13, 2021 EEXT
TEAS STATEMENT OF USE RECEIVED
Oct 13, 2021 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 6, 2021 EXRA
SOU EXTENSION 4 GRANTED
May 4, 2021 EX4G
SOU EXTENSION 4 FILED
May 4, 2021 EXT4
SOU TEAS EXTENSION RECEIVED
May 4, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 12, 2020 EXRA
SOU EXTENSION 3 GRANTED
Nov 10, 2020 EX3G
SOU EXTENSION 3 FILED
Nov 10, 2020 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 10, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 8, 2020 EXRA
SOU EXTENSION 2 GRANTED
May 6, 2020 EX2G
SOU EXTENSION 2 FILED
May 6, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
May 6, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 23, 2019 EXRA
SOU EXTENSION 1 GRANTED
Oct 21, 2019 EX1G
SOU EXTENSION 1 FILED
Oct 21, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 21, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 21, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 26, 2019 NPUB
PUBLISHED FOR OPPOSITION
Mar 26, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 6, 2019 NONP
ASSIGNED TO LIE
Feb 15, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 4, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 1, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 31, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 28, 2019 GNFN
FINAL REFUSAL E-MAILED
Jan 28, 2019 GNFR
FINAL REFUSAL WRITTEN
Jan 28, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 3, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 2, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 2, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 23, 2018 GNRN
NON-FINAL ACTION E-MAILED
Oct 23, 2018 GNRT
NON-FINAL ACTION WRITTEN
Oct 23, 2018 CNRT
ASSIGNED TO EXAMINER
Oct 23, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2018 NWOS
NEW APPLICATION ENTERED
Jul 6, 2018 NWAP

Related Trademarks

More from this Owner

FUZIONAIRE DIAGNOSTICS

FUZIONAIRE DIAGNOSTICS

FUZIONAIRE DIAGNOSTICS

FUZIONAIRE DIAGNOSTICS

FUZIONAIRE DIAGNOSTICS

FUZIONAIRE DIAGNOSTICS

FUZIONAIRE

FUZIONAIRE

FUZIONAIRE

FUZIONAIRE

FUZIONAIRE

FUZIONAIRE